GlmS plays a key role in the virulence factor expression and biofilm formation ability of Staphylococcus aureus promoted by advanced glycation end products

is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA rele...

Full description

Saved in:
Bibliographic Details
Published inVirulence Vol. 15; no. 1; p. 2352476
Main Authors Ni, Lijia, Shen, Rui, Luo, Hua, Li, Xuexue, Zhang, Xiaofan, Huang, Lisi, Deng, Yawen, Liao, Xiaoyan, Wu, Yonglin, Duan, Chaohui, Xie, Xiaoying
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.12.2024
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via upregulation in , contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of in stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of . We constructed NCTC 8325 ∆ for further validation. qRT-PCR analysis revealed that AGEs promoted both and expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆ . NCTC 8325 ∆ showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of and expression, and less and sparser biofilms, indicated that and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆ . Our data extend the understanding of GlmS in the global regulatory network of and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates and plays a significant role in mediating biofilm formation and virulence factor expression.
AbstractList Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via sigB upregulation in S. aureus, contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of sigB in S. aureus stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of sigB. We constructed NCTC 8325 ∆glmS for further validation. qRT-PCR analysis revealed that AGEs promoted both glmS and sigB expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆glmS. NCTC 8325 ∆glmS showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in sigB expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of hla and hld expression, and less and sparser biofilms, indicated that sigB and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆glmS. Our data extend the understanding of GlmS in the global regulatory network of S. aureus and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates sigB and plays a significant role in mediating biofilm formation and virulence factor expression.
Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via sigB upregulation in S. aureus, contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of sigB in S. aureus stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of sigB. We constructed NCTC 8325 ∆glmS for further validation. qRT-PCR analysis revealed that AGEs promoted both glmS and sigB expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆glmS. NCTC 8325 ∆glmS showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in sigB expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of hla and hld expression, and less and sparser biofilms, indicated that sigB and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆glmS. Our data extend the understanding of GlmS in the global regulatory network of S. aureus and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates sigB and plays a significant role in mediating biofilm formation and virulence factor expression.Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via sigB upregulation in S. aureus, contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of sigB in S. aureus stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of sigB. We constructed NCTC 8325 ∆glmS for further validation. qRT-PCR analysis revealed that AGEs promoted both glmS and sigB expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆glmS. NCTC 8325 ∆glmS showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in sigB expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of hla and hld expression, and less and sparser biofilms, indicated that sigB and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆glmS. Our data extend the understanding of GlmS in the global regulatory network of S. aureus and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates sigB and plays a significant role in mediating biofilm formation and virulence factor expression.
is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via upregulation in , contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of in stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of . We constructed NCTC 8325 ∆ for further validation. qRT-PCR analysis revealed that AGEs promoted both and expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆ . NCTC 8325 ∆ showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of and expression, and less and sparser biofilms, indicated that and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆ . Our data extend the understanding of GlmS in the global regulatory network of and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates and plays a significant role in mediating biofilm formation and virulence factor expression.
Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycaemia in diabetic tissues, enhanced biofilm formation by promoting eDNA release via sigB upregulation in S. aureus , contributing to the high morbidity and mortality of patients presenting a diabetic foot ulcer infection. However, the exact regulatory network has not been completely described. Here, we used pull-down assay and LC-MS/MS to identify the GlmS as a candidate regulator of sigB in S. aureus stimulated by AGEs. Dual-luciferase assays and electrophoretic mobility shift assays (EMSAs) revealed that GlmS directly upregulated the transcriptional activity of sigB . We constructed NCTC 8325 ∆ glmS for further validation. qRT-PCR analysis revealed that AGEs promoted both glmS and sigB expression in the NCTC 8325 strain but had no effect on NCTC 8325 ∆ glmS . NCTC 8325 ∆ glmS showed a significant attenuation in biofilm formation and virulence factor expression, accompanied by a decrease in sigB expression, even under AGE stimulation. All of the changes, including pigment deficiency, decreased haemolysis ability, downregulation of hla and hld expression, and less and sparser biofilms, indicated that sigB and biofilm formation ability no longer responded to AGEs in NCTC 8325 ∆ glmS . Our data extend the understanding of GlmS in the global regulatory network of S. aureus and demonstrate a new mechanism by which AGEs can upregulate GlmS, which directly regulates sigB and plays a significant role in mediating biofilm formation and virulence factor expression.
Author Deng, Yawen
Luo, Hua
Ni, Lijia
Shen, Rui
Li, Xuexue
Huang, Lisi
Wu, Yonglin
Duan, Chaohui
Zhang, Xiaofan
Liao, Xiaoyan
Xie, Xiaoying
Author_xml – sequence: 1
  givenname: Lijia
  surname: Ni
  fullname: Ni, Lijia
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 2
  givenname: Rui
  surname: Shen
  fullname: Shen, Rui
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 3
  givenname: Hua
  surname: Luo
  fullname: Luo, Hua
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 4
  givenname: Xuexue
  surname: Li
  fullname: Li, Xuexue
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 5
  givenname: Xiaofan
  surname: Zhang
  fullname: Zhang, Xiaofan
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 6
  givenname: Lisi
  surname: Huang
  fullname: Huang, Lisi
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 7
  givenname: Yawen
  surname: Deng
  fullname: Deng, Yawen
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 8
  givenname: Xiaoyan
  surname: Liao
  fullname: Liao, Xiaoyan
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 9
  givenname: Yonglin
  surname: Wu
  fullname: Wu, Yonglin
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 10
  givenname: Chaohui
  orcidid: 0000-0003-3130-5045
  surname: Duan
  fullname: Duan, Chaohui
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 11
  givenname: Xiaoying
  orcidid: 0000-0002-6113-6505
  surname: Xie
  fullname: Xie, Xiaoying
  organization: Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, Institution of Antibiotic, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38741276$$D View this record in MEDLINE/PubMed
BookMark eNqFkstu1TAQhiNUREvpI4C8ZHOKHV-SiAVCFZRKlVgU1pZjj89xceJgOxV5Fl4Wn1tF2eCFxxr__ze2Zl5WJ2MYoapeE3xJcIvf1YRjzjt2WeO6bJTXrBHPqrNtfsUFbk-O5yI6rS5SusdlsZYU24vqlLYNI3Ujzqrf1364Q5NXS0IK_YAFxeABuRHlDaAHF2cPowZklc4hIvg1RUjJhRGp0aDeBev8gGyIg8q7bO-8ywsKFt1lNW0WH3TQei70OUIJUwxDyFC8C1LmQRW4QWu_6L0fCrVIzKxzelU9t8onuDjE8-r750_frr6sbr9e31x9vF1p1rR5ZbsOOsyZbijrrebCmEYYaygwZhtjTM8b1fQUQ0-IUBao6RotKDGCcVsbel7d7LkmqHs5RTeouMignNwlQlxLFbPTHqSoe00o6BYTYIKbjoPQUDNiFe570hXWhz1rmvsBjIYxR-WfQJ_ejG4j1-FBEoI7zhtWCG8PhBh-zpCyHFzS4L0aIcxJ0vLVlna8JkX65u9ij1WO7S0CvhfoGFKKYB8lBMvtJMnjJMntJMnDJBXf-3982uVdg8qbnf-P-w-RXtHo
CitedBy_id crossref_primary_10_5306_wjco_v15_i9_1117
crossref_primary_10_1021_acscentsci_4c01167
crossref_primary_10_3390_amh70010009
Cites_doi 10.3389/fcimb.2019.00157
10.1126/science.1153018
10.1093/humrep/det419
10.1021/cb200016d
10.1007/BF00282455
10.1167/iovs.63.6.25
10.3389/fpls.2022.948751
10.3390/cells11081312
10.1002/chem.202202378
10.3892/ol.2017.7127
10.1007/978-1-0716-1550-8_9
10.1016/j.plasmid.2005.05.005
10.1128/JB.01000-07
10.3389/fcimb.2015.00001
10.1038/s41426-018-0078-1
10.3389/fmicb.2022.967567
10.4161/viru.2.5.17724
10.1016/j.biomaterials.2012.05.031
10.1007/s11892-013-0453-1
10.1152/ajpcell.00267.2021
10.1016/j.intimp.2021.107806
10.1002/eji.201948477
10.1021/ar200039b
10.1111/lam.13456
10.1016/j.ijfoodmicro.2021.109499
10.3390/cells11142178
10.7554/eLife.54983
10.1093/nar/gkab1038
10.1017/S0033583510000144
10.3389/fmicb.2020.01479
10.1111/j.1365-2958.2004.04200.x
10.1016/j.jhep.2021.08.027
10.2174/0929866526666190822162140
10.1007/s11274-021-03004-7
10.3389/fmicb.2021.672943
10.1021/acssynbio.1c00443
10.1038/s41598-020-78379-y
10.1126/science.1129666
10.1155/2017/8694903
10.1261/rna.2590811
10.1016/0378-1119(95)00732-6
ContentType Journal Article
Copyright 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s)
Copyright_xml – notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1080/21505594.2024.2352476
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate L. NI ET AL
EISSN 2150-5608
ExternalDocumentID oai_doaj_org_article_62bc13ec801e465d95e6ce241fa0bb19
PMC11095574
38741276
10_1080_21505594_2024_2352476
Genre Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 82002203]
– fundername: Basic and Applied Basic Research Foundation of Guangdong Province
  grantid: 2023A1515010089
GroupedDBID ---
0YH
53G
AAYXX
ABDBF
ABPEM
ACGFS
ACUHS
ADBBV
ADCVX
AENEX
AIJEM
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
EBS
EMOBN
ESX
F5P
GROUPED_DOAJ
GTTXZ
H13
HZ~
O9-
OK1
RPM
SV3
TDBHL
TFL
TFW
TR2
TUS
4.4
ABCCY
C1A
CGR
CUY
CVF
DGEBU
DIK
ECM
EIF
EJD
HYE
M4Z
NPM
OVD
TEORI
TTHFI
7X8
5PM
ID FETCH-LOGICAL-c478t-f99e9054c734bfc56dd76dfd3e44f7dddb57a7b30eb116afe3d97c631d645f2d3
IEDL.DBID DOA
ISSN 2150-5594
2150-5608
IngestDate Wed Aug 27 01:11:24 EDT 2025
Thu Aug 21 18:35:43 EDT 2025
Thu Jul 10 17:00:58 EDT 2025
Sat Mar 01 01:25:46 EST 2025
Tue Jul 01 01:22:34 EDT 2025
Thu Apr 24 22:53:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords GlmS-sigB regulatory axis
biofilm formation
advanced glycation end products
virulence factor expression
Staphylococcus aureus
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c478t-f99e9054c734bfc56dd76dfd3e44f7dddb57a7b30eb116afe3d97c631d645f2d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ORCID 0000-0002-6113-6505
0000-0003-3130-5045
OpenAccessLink https://doaj.org/article/62bc13ec801e465d95e6ce241fa0bb19
PMID 38741276
PQID 3054839521
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_62bc13ec801e465d95e6ce241fa0bb19
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11095574
proquest_miscellaneous_3054839521
pubmed_primary_38741276
crossref_primary_10_1080_21505594_2024_2352476
crossref_citationtrail_10_1080_21505594_2024_2352476
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-12-00
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Virulence
PublicationTitleAlternate Virulence
PublicationYear 2024
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References e_1_3_7_40_1
e_1_3_7_41_1
e_1_3_7_21_1
e_1_3_7_44_1
e_1_3_7_20_1
e_1_3_7_23_1
e_1_3_7_42_1
e_1_3_7_22_1
e_1_3_7_43_1
e_1_3_7_25_1
e_1_3_7_27_1
e_1_3_7_26_1
e_1_3_7_29_1
e_1_3_7_28_1
Liu H (e_1_3_7_30_1) 2018; 7
Li Z (e_1_3_7_15_1) 2020; 39
Zhang L (e_1_3_7_24_1) 2022; 10
e_1_3_7_32_1
e_1_3_7_10_1
e_1_3_7_31_1
e_1_3_7_11_1
e_1_3_7_34_1
e_1_3_7_12_1
e_1_3_7_33_1
e_1_3_7_13_1
e_1_3_7_36_1
e_1_3_7_14_1
e_1_3_7_35_1
e_1_3_7_38_1
e_1_3_7_16_1
e_1_3_7_37_1
e_1_3_7_17_1
e_1_3_7_18_1
e_1_3_7_39_1
e_1_3_7_19_1
e_1_3_7_3_1
e_1_3_7_2_1
e_1_3_7_5_1
e_1_3_7_4_1
e_1_3_7_7_1
e_1_3_7_6_1
e_1_3_7_9_1
e_1_3_7_8_1
References_xml – ident: e_1_3_7_26_1
  doi: 10.3389/fcimb.2019.00157
– ident: e_1_3_7_44_1
  doi: 10.1126/science.1153018
– ident: e_1_3_7_7_1
  doi: 10.1093/humrep/det419
– ident: e_1_3_7_36_1
  doi: 10.1021/cb200016d
– ident: e_1_3_7_10_1
  doi: 10.1007/BF00282455
– ident: e_1_3_7_20_1
  doi: 10.1167/iovs.63.6.25
– ident: e_1_3_7_25_1
  doi: 10.3389/fpls.2022.948751
– ident: e_1_3_7_39_1
  doi: 10.3390/cells11081312
– ident: e_1_3_7_14_1
  doi: 10.1002/chem.202202378
– ident: e_1_3_7_19_1
  doi: 10.3892/ol.2017.7127
– ident: e_1_3_7_29_1
  doi: 10.1007/978-1-0716-1550-8_9
– ident: e_1_3_7_23_1
  doi: 10.1016/j.plasmid.2005.05.005
– ident: e_1_3_7_22_1
  doi: 10.1128/JB.01000-07
– ident: e_1_3_7_5_1
  doi: 10.3389/fcimb.2015.00001
– volume: 7
  start-page: 1
  year: 2018
  ident: e_1_3_7_30_1
  article-title: A novel SigB(Q225P) mutation in Staphylococcus aureus retains virulence but promotes biofilm formation
  publication-title: Emerg Microbes Infect
  doi: 10.1038/s41426-018-0078-1
– ident: e_1_3_7_32_1
  doi: 10.3389/fmicb.2022.967567
– ident: e_1_3_7_2_1
  doi: 10.4161/viru.2.5.17724
– ident: e_1_3_7_3_1
  doi: 10.1016/j.biomaterials.2012.05.031
– ident: e_1_3_7_6_1
  doi: 10.1007/s11892-013-0453-1
– ident: e_1_3_7_21_1
  doi: 10.1152/ajpcell.00267.2021
– ident: e_1_3_7_41_1
  doi: 10.1016/j.intimp.2021.107806
– ident: e_1_3_7_8_1
  doi: 10.1002/eji.201948477
– ident: e_1_3_7_12_1
  doi: 10.1021/ar200039b
– ident: e_1_3_7_33_1
  doi: 10.1111/lam.13456
– volume: 39
  start-page: 1
  issue: 1
  year: 2020
  ident: e_1_3_7_15_1
  article-title: Targeting HMGB3/hTERT axis for radioresistance in cervical cancer
  publication-title: J Exp Clin Cancer Res [internet]
– ident: e_1_3_7_31_1
  doi: 10.1016/j.ijfoodmicro.2021.109499
– ident: e_1_3_7_40_1
  doi: 10.3390/cells11142178
– ident: e_1_3_7_16_1
  doi: 10.7554/eLife.54983
– ident: e_1_3_7_17_1
  doi: 10.1093/nar/gkab1038
– ident: e_1_3_7_11_1
  doi: 10.1017/S0033583510000144
– ident: e_1_3_7_9_1
  doi: 10.3389/fmicb.2020.01479
– ident: e_1_3_7_13_1
  doi: 10.1111/j.1365-2958.2004.04200.x
– ident: e_1_3_7_38_1
  doi: 10.1016/j.jhep.2021.08.027
– volume: 10
  start-page: e00363
  issue: 4
  year: 2022
  ident: e_1_3_7_24_1
  article-title: Development and application of two inducible expression systems for Streptococcus suis
  publication-title: Microbiol Spectr [Internet]
– ident: e_1_3_7_18_1
  doi: 10.2174/0929866526666190822162140
– ident: e_1_3_7_42_1
  doi: 10.1007/s11274-021-03004-7
– ident: e_1_3_7_28_1
  doi: 10.3389/fmicb.2021.672943
– ident: e_1_3_7_35_1
  doi: 10.1021/acssynbio.1c00443
– ident: e_1_3_7_27_1
  doi: 10.1038/s41598-020-78379-y
– ident: e_1_3_7_37_1
  doi: 10.1126/science.1129666
– ident: e_1_3_7_4_1
  doi: 10.1155/2017/8694903
– ident: e_1_3_7_43_1
  doi: 10.1261/rna.2590811
– ident: e_1_3_7_34_1
  doi: 10.1016/0378-1119(95)00732-6
SSID ssj0000481055
Score 2.3945475
Snippet is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that...
Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We...
Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2352476
SubjectTerms advanced glycation end products
Bacterial Proteins - genetics
Bacterial Proteins - metabolism
biofilm formation
Biofilms - growth & development
Gene Expression Regulation, Bacterial
GlmS-sigB regulatory axis
Glycation End Products, Advanced - metabolism
Humans
Sigma Factor - genetics
Sigma Factor - metabolism
Staphylococcal Infections - microbiology
Staphylococcus aureus
Staphylococcus aureus - genetics
Staphylococcus aureus - pathogenicity
virulence factor expression
Virulence Factors - genetics
Title GlmS plays a key role in the virulence factor expression and biofilm formation ability of Staphylococcus aureus promoted by advanced glycation end products
URI https://www.ncbi.nlm.nih.gov/pubmed/38741276
https://www.proquest.com/docview/3054839521
https://pubmed.ncbi.nlm.nih.gov/PMC11095574
https://doaj.org/article/62bc13ec801e465d95e6ce241fa0bb19
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9NAFB50QfBFvFsvyxF8rdtkbsmjimsR9EUX1qcwVy1009I2Yn6Lf9ZzZpLSirAvQkhgkkmGnDNnvknOfB9jr6IR3BhOCU-VwgkKurHRUmAwjFwq7euQPl18-qzmF-Ljpbw8kPqinLBMD5xf3JkqrSt4cBhJg1DS1zKQiJUooplZmwg_SxzzDiZTKQaLipQfSVkOEc8UYbMYl-9UszMqoyKcHpa4QwwiiHPkYGBK_P3_Ap1_504eDEbnd9mdAUXCm9z6e-xGaO-zW1lXsn_Afn9YXn2B9dL0WzCA3RQoiRAWLSDcg5-LTZeWGkEW24Hwa8iGbcG0HuyCZLyvYL-uETKXdw-rCAhO0TA4Aq6c6_Du3SbgYZ2S-gLW7WHMKoDvyz5_D4SAd11natntQ3Zx_v7ru_l0UGGYOqGr3TTWaC8Edk5zYaOTynutfPQ8CBG1995KbbTlM4z6hTIxcF9rp3jhlZCx9PwRO2lXbXjCoPRS4xaF9oUwtUPzaRO9tBhVoi7KCROjCRo3UJSTUsayKQYm09FyDVmuGSw3Ya_31daZo-O6Cm_JvvuLiWI7FaDjNYPjNdc53oS9HL2jwS5J_1lMG1bdtsEQKhB3IjCasMfZW_aP4hVCuJKaUB350VFbjs-0ix-J9pu4YaXU4un_aP0zdpveSE7Mec5OdpsuvEB4tbOn7Obs2_w09ac_SLAiKA
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GlmS+plays+a+key+role+in+the+virulence+factor+expression+and+biofilm+formation+ability+of+Staphylococcus+aureus+promoted+by+advanced+glycation+end+products&rft.jtitle=Virulence&rft.au=Lijia+Ni&rft.au=Rui+Shen&rft.au=Hua+Luo&rft.au=Xuexue+Li&rft.date=2024-12-01&rft.pub=Taylor+%26+Francis+Group&rft.issn=2150-5594&rft.eissn=2150-5608&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1080%2F21505594.2024.2352476&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_62bc13ec801e465d95e6ce241fa0bb19
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2150-5594&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2150-5594&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2150-5594&client=summon